aminoimidazole carboxamide has been researched along with Alloxan Diabetes in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, XJ; Chen, X; Qian, HY; Sun, YZ; Wu, R; Xu, GY; Zhang, PA; Zhu, HY | 1 |
| Habib, SL; Liang, S; Nayak, BK; Vogel, KS | 1 |
| Bhatt, MP; Ha, KS; Kim, YM; Lim, YC | 1 |
| Ali, SS; Andreyev, A; Brosius, F; Chepetan, A; DeCleves, AE; Diamond-Stanic, M; Dugan, LL; Fogo, A; Le, TP; Ly, S; Miyamoto, S; Murphy, A; Naviaux, RK; Nguyen, W; Paik, KP; Quach, T; Sharma, K; Shekhtman, G; Viollet, B; Wang, L; Xu, M; You, YH | 1 |
| Inaba, T; Ito, A; Kawashima, M; Morimoto, K; Sano, K; Tsubota, K; Watanabe, M | 1 |
| Miyamoto, S; Sharma, K; You, YH; Zhao, J | 1 |
| Dong, H; Jiang, SJ; Li, JB; Lu, FE; Wang, KF; Xu, LJ; Yi, P; Zou, X | 1 |
| Chen, AF; Chen, DD; Wang, XR; Zhang, MW; Zhang, Y | 1 |
| Cao, Y; Gao, E; Lau, WB; Lian, K; Liu, S; Liu, Y; Lu, X; Ma, Y; Pei, H; Qu, Y; Sun, L; Tao, L; Wang, H; Wang, R; Xia, C; Yang, L; Yin, T | 1 |
| Ishida, S; Kubota, S; Kurihara, T; Miyake, S; Noda, K; Ozawa, Y; Sasaki, M; Tsubota, K; Yuki, K | 1 |
| Alford, FP; Chen, ZP; Christopher, M; Kemp, B; Rantzau, C; Snow, R | 1 |
| Choudhury, GG; Feliers, D; Foretz, M; Kasinath, BS; Lee, MJ; Mahimainathan, L; Mariappan, MM; Musi, N; Sataranatarajan, K; Viollet, B; Weinberg, JM | 1 |
| Akkan, AG; Bolkent, S; Kaya-Dagistanli, F; Ozturk, M; Tuncdemir, M; Yilmazer, S | 1 |
| Chang, AS; Chi, MM; Moley, KH; Ratchford, AM; Sheridan, R | 1 |
| Bendayan, M; Cammisotto, PG; Gingras, D; Londono, I | 1 |
| Akkan, AG; Ince, E; Kaya, F; Ozturk, M; Ozyazgan, S; Senses, V; Sultuybek, G; Tuncdemir, M | 1 |
| Ensor, NJ; Gulve, EA; Halseth, AE; Ross, SA; White, TA | 1 |
17 other study(ies) available for aminoimidazole carboxamide and Alloxan Diabetes
| Article | Year |
|---|---|
Metformin attenuates diabetic neuropathic pain via AMPK/NF-κB signaling pathway in dorsal root ganglion of diabetic rats.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Ganglia, Spinal; Hyperalgesia; Hypoglycemic Agents; Male; MAP Kinase Signaling System; Metformin; Neuralgia; NF-kappa B; Rats; Rats, Sprague-Dawley; Ribonucleotides | 2021 |
TP63 Is Significantly Upregulated in Diabetic Kidney.
Topics: Adenylate Kinase; Aminoimidazole Carboxamide; Animals; Blood Glucose; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Down-Regulation; Hypoxia-Inducible Factor 1, alpha Subunit; Insulin Receptor Substrate Proteins; Kidney Tubules, Proximal; Models, Biological; Ribonucleotides; RNA, Messenger; Signal Transduction; Trans-Activators; Tuberous Sclerosis Complex 2 Protein; Up-Regulation | 2021 |
C-peptide activates AMPKα and prevents ROS-mediated mitochondrial fission and endothelial apoptosis in diabetes.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Apoptosis; C-Peptide; Cells, Cultured; Cytosol; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Enzyme Activation; Glucose; Human Umbilical Vein Endothelial Cells; Humans; Male; Membrane Potential, Mitochondrial; Metformin; Mice; Mice, Inbred C57BL; Mitochondrial Dynamics; Reactive Oxygen Species | 2013 |
AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Activation; Humans; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Knockout; Mitochondria; Pyruvate Dehydrogenase Complex; Ribonucleotides; Rotenone; Superoxide Dismutase; Superoxides | 2013 |
Aerobic exercise increases tear secretion in type 2 diabetic mice.
Topics: Aminoimidazole Carboxamide; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Hypoglycemic Agents; Injections, Intraperitoneal; Mice; Mice, Inbred C57BL; Oxidative Stress; Physical Conditioning, Animal; Ribonucleotides; Tears | 2014 |
AMP-activated protein kinase (AMPK) activation inhibits nuclear translocation of Smad4 in mesangial cells and diabetic kidneys.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Biological Transport; Cell Line; Cell Nucleus; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Glucose; Hypoglycemic Agents; In Vitro Techniques; Male; Mesangial Cells; Mice; Mice, Inbred C57BL; Ribonucleotides; Signal Transduction; Smad4 Protein; Streptozocin; Transforming Growth Factor beta | 2015 |
Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats.
Topics: Active Transport, Cell Nucleus; Aminoimidazole Carboxamide; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; Berberine; Biomarkers; Blood Glucose; Diabetes Mellitus, Experimental; Gluconeogenesis; Glucose-6-Phosphatase; Hyperlipidemias; Hypoglycemic Agents; Insulin; Insulin Resistance; Intracellular Signaling Peptides and Proteins; Lipids; Liver; Male; Metformin; Phosphoenolpyruvate Carboxykinase (GTP); Phosphorylation; Protein Serine-Threonine Kinases; Rats, Wistar; Ribonucleotides; Signal Transduction; Streptozocin; Time Factors; Trans-Activators; Up-Regulation | 2015 |
AMP-activated protein kinase rescues the angiogenic functions of endothelial progenitor cells via manganese superoxide dismutase induction in type 1 diabetes.
Topics: Adenoviridae; Aminoimidazole Carboxamide; Animals; Blotting, Western; Bone Marrow Cells; Bone Marrow Transplantation; Cell Adhesion; Cell Movement; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Endothelial Cells; Male; Mice; Mice, Inbred C57BL; Microtubules; Mitochondria; Neovascularization, Physiologic; Protein Phosphatase 2; Ribonucleotides; RNA, Small Interfering; Stem Cells; Superoxide Dismutase; Transfection | 2011 |
Dynamic alteration of adiponectin/adiponectin receptor expression and its impact on myocardial ischemia/reperfusion in type 1 diabetic mice.
Topics: Adenylate Kinase; Adiponectin; Aminoimidazole Carboxamide; Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Mice; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Receptors, Adiponectin; Ribonucleotides | 2011 |
Roles of AMP-activated protein kinase in diabetes-induced retinal inflammation.
Topics: Administration, Oral; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Blotting, Western; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Inflammation; Injections, Intraperitoneal; Intercellular Adhesion Molecule-1; Mice; Mice, Inbred C57BL; Phosphorylation; Resveratrol; Retinitis; Ribonucleotides; Sirtuin 1; Stilbenes; Transcription Factor RelA; Vascular Endothelial Growth Factor A | 2011 |
Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion.
Topics: Acetyl-CoA Carboxylase; Adenosine Monophosphate; Adenosine Triphosphate; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dogs; Epoxy Compounds; Fatty Acids; Glucagon; Glucose; Glucosephosphate Dehydrogenase; Glycogen; Hypoglycemic Agents; Insulin; Lactic Acid; Male; Multienzyme Complexes; Muscle, Skeletal; Oxidation-Reduction; Propionates; Protein Serine-Threonine Kinases; Ribonucleotides; Serine | 2006 |
A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Carrier Proteins; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glucose; Hypertrophy; Intracellular Signaling Peptides and Proteins; Kidney; Metformin; Multienzyme Complexes; Phosphoproteins; Protein Serine-Threonine Kinases; Rats; Ribonucleosides; Transforming Growth Factor beta | 2007 |
The effects of 5-aminoimidazole-4-carboxamide riboside on the pancreas in neonatal streptozotocin-diabetic rats.
Topics: Aminoimidazole Carboxamide; Animals; Animals, Newborn; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Pancreas; Rats; Ribonucleotides; RNA, Messenger | 2006 |
Maternal diabetes adversely affects AMP-activated protein kinase activity and cellular metabolism in murine oocytes.
Topics: 3-Hydroxyacyl CoA Dehydrogenases; Acetyl-CoA Carboxylase; Adenosine Monophosphate; Adenosine Triphosphate; Alanine Transaminase; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Diabetes Mellitus, Experimental; Enzyme Activation; Female; Hypoglycemic Agents; Metformin; Mice; Mice, Inbred C57BL; Multienzyme Complexes; Oocytes; Pregnancy; Pregnancy in Diabetics; Protein Serine-Threonine Kinases; Ribonucleotides; Streptozocin | 2007 |
Control of glycogen synthase through ADIPOR1-AMPK pathway in renal distal tubules of normal and diabetic rats.
Topics: Adenylate Kinase; Adiponectin; Aminoimidazole Carboxamide; Animals; Diabetes Mellitus, Experimental; Glycogen Synthase; Immunohistochemistry; Kidney; Kidney Tubules, Distal; Male; Rats; Rats, Sprague-Dawley; Receptors, Adiponectin; Ribonucleotides | 2008 |
Effect of 5-aminoimidazole-4-carboxamide riboside (AICA-r) on isolated thoracic aorta responses in streptozotocin-diabetic rats.
Topics: Acetylcholine; Aminoimidazole Carboxamide; Animals; Aorta, Thoracic; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Endothelium, Vascular; Female; Injections, Intraperitoneal; Male; Nitroprusside; Norepinephrine; Rats; Rats, Wistar; Ribonucleosides; Vasoconstriction; Vasodilation | 2001 |
Acute and chronic treatment of ob/ob and db/db mice with AICAR decreases blood glucose concentrations.
Topics: Adenosine Monophosphate; Aminoimidazole Carboxamide; Animals; Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Enzyme Activation; Female; Glucose Transporter Type 1; Glucose Transporter Type 4; Hypoglycemic Agents; Male; Mice; Mice, Obese; Monosaccharide Transport Proteins; Muscle Proteins; Muscles; Ribonucleotides; Time Factors; Triglycerides | 2002 |